Mastodon

CalciyOsteon (Tablets) Instructions for Use

Marketing Authorization Holder

Higlance Laboratories Pvt. Ltd. (India)

Contact Information

HIGLANCE LABORATORIES (India)

Dosage Form

Bottle OTC Icon CalciyOsteon Lozenges: 30 pcs.

Dosage Form, Packaging, and Product Composition

Orange-flavored lozenges.

1 tab.
Calcium (as calcium carbonate) 500 mg
Colecalciferol (vitamin D3) 400 IU

Dosage form and packaging
Orange-flavored lozenges weighing 1700 mg.
15 pcs. – blisters (2) – cardboard packs.

Therapeutic Category

Dietary supplement for strengthening bone tissue and preventing osteoporosis

Scope of Application

Of the CalciyOsteon product

Recommended as a dietary supplement – an additional source of calcium and vitamin D3.

Indications

This dietary supplement is indicated as an additional source of calcium and vitamin D3 for individuals with deficiencies or increased requirements.

  • To supplement dietary intake of calcium and vitamin D3.
  • For supporting bone health and strength.
  • As an adjunct for the prevention of osteoporosis in at-risk individuals.

ICD codes

ICD-10 code Indication
E55.9 Unspecified vitamin D deficiency
E58 Dietary calcium deficiency
ICD-11 code Indication
5B57.Z Vitamin D deficiency, unspecified
5B5K.1Z Calcium deficiency, unspecified
8D40.2 Myopathy due to nutritional deficiency

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take one lozenge daily with a meal to improve absorption and minimize potential gastrointestinal discomfort.

Adhere to the recommended duration of intake of four weeks. Do not exceed the stated dose. This product is not a medicine.

Adverse Reactions

Adverse reactions are uncommon but may include gastrointestinal effects such as constipation, flatulence, or nausea.

Discontinue use immediately if any signs of an allergic reaction occur, including rash, itching, or swelling. Report any persistent or severe adverse effects to a healthcare professional.

Drug Interactions

Calcium can reduce the absorption of several medications. Maintain a minimum interval of two to three hours between taking this supplement and other drugs.

Exercise particular caution with tetracycline and fluoroquinolone antibiotics, bisphosphonates, levothyroxine, and phenytoin. Consult a healthcare provider for potential interactions.

Contraindications

The use of this product is contraindicated in the following conditions:

  • Known hypersensitivity or individual intolerance to any component of the formulation.
  • Patients with phenylketonuria, due to the presence of aspartame.
  • During pregnancy and throughout the breastfeeding period.
  • In cases of hypercalcemia or hypercalciuria.

Consult a doctor before initiating use.

Overdose

Symptoms of overdose are consistent with hypercalcemia and hypervitaminosis D, including nausea, vomiting, loss of appetite, constipation, abdominal pain, fatigue, and mental confusion.

In case of suspected overdose, discontinue use immediately and seek medical attention. Treatment is supportive and includes withdrawal of calcium and vitamin D intake.

Dispensing Status

Sold to the public through pharmacy chains and specialized stores, departments of the retail network.

Storage Conditions

In a dry place, protected from light and out of reach of children, at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life 2 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Table of Contents

→ TABLE OF CONTENTS